Director, Global Commercial Strategy, Iza-bren

About the role

Working at Bristol Myers Squibb is anything but usual. Here, uniquely interesting work happens every day, in every department—from optimizing a production line to the latest breakthroughs in cell therapy. This role is an integral part of the Global Commercial Strategy (GCS) team, reporting to the VP, Global Commercial Strategy Lead. The Director, Global Commercial Strategy, Iza-bren will lead the global commercial strategy for key indications of iza-bren (EGFRxHER3 bispecific ADC), partnering closely with Clinical Development, Biostatistics, Regulatory, Forecasting/Competitive Intelligence, Market Access, and Medical. The candidate must thrive in a fast-paced, ambiguous environment, translating clinical and scientific uncertainty into clear commercial perspective and executive-ready strategic direction.

Responsibilities

• Own commercial asset strategy for assigned iza-bren indication(s), ensuring alignment with the GPT team and broader oncology portfolio strategy.
• Lead development and iterative refinement of Target Product Profiles (TPPs), including designing and pressure-testing market research, gaining TL feedback, and utilizing analogs to validate share/utilization assumptions.
• Lead and continuously refine commercial forecasting, market sizing, and revenue/valuation models; translate clinical, regulatory, or biomarker-inclusion changes into quantified commercial recommendations for cross-functional decision-making, and make clear recommendations under uncertainty.
• Shape and evolve the Clinical Development Plan (CDP) in partnership with Clinical Development, informing indication and study prioritization based on commercial assessment, competitive dynamics, and portfolio trade-offs.
• Develop executive-level governance narratives and materials that translate complex clinical and commercial data into clear, decision-ready recommendations for senior leadership and governance forums.
• Monitor and synthesize the relevant competitive landscape, proactively flagging implications for iza-bren strategy and commercial opportunity.
• Build and maintain excellent stakeholder networks across the GPT, global commercial strategy team, key regional partners, and matrix functions to advance business objectives and ensure smooth progress as the program moves through key inflection points.
• Represent commercial strategy in the BMS/SystImmune alliance and governance forums, ensuring commercial input is reflected in joint decision-making on trial design, label strategy, and lifecycle planning.

Qualifications & Experience

• BS/BA or equivalent required; an MBA or other advanced degree preferred.
• Minimum 6-8 years of pharmaceutical/biotech commercial strategy, marketing, or top-tier consulting experience; oncology experience strongly preferred.
• Experience shaping Clinical Development Plan (CDP) evolution and/or indication prioritization in partnership with Clinical Development.
• Demonstrated end-to-end asset strategy experience in oncology, spanning early development through launch and lifecycle management.
• Experience with global launch sequencing and prioritization across markets and indications.
• Demonstrated experience with pre-launch commercialization TPP development, market research design, forecasting/valuation, and CIP/CSRE-style planning processes.
• Strong ability to translate complex clinical, scientific, and regulatory data into clear, actionable commercial decisions and recommendations, including comfort making recommendations under uncertainty.
• Proven ability to develop executive-level governance narratives and materials, coupled with strong interpersonal and verbal communication skills.
• Experience representing commercial interests in alliance/partnership governance structures (e.g., joint program/joint steering committees) is a plus.
• Demonstrated success mobilizing cross-functional matrix teams (Clinical, Biostatistics, Regulatory, Market Access, Medical, Forecasting) to drive aligned, timely decisions.
• Well organized, with a demonstrated ability to build a practical workplan, prioritize with autonomy, hold and respect meeting cadences, and manage multiple concurrent workstreams with speed.
• Personal integrity; passionate, energetic, and focused on the company and mission.
• Listens/considers alternative ideas and viewpoints and encourages debate on others' ideas.
• Capacity to grow, develop, and learn from experience.
• Excellent interpersonal and communication skills.

Pay

The starting compensation range for this full-time role is $198,130 - $240,083 (Princeton, NJ, US). Additional incentive cash and stock opportunities (based on eligibility) may be available. The starting pay rate accounts for required skills, job location, work schedule, job-related knowledge, and experience. Final, individual compensation will be decided based on demonstrated experience.

Benefits

• Health Coverage: Medical, pharmacy, dental, and vision care.
• Wellbeing Support Programs: BMS Well-Being Account, BMS Living Life Better, and Employee Assistance Programs (EAP).
• Financial Well-being and Protection: 401(k) plan, short- and long-term disability, life insurance, accident insurance, supplemental health insurance, business travel protection, personal liability protection, identity theft benefit, legal support, and survivor support.
• Work-life Benefits:
  • Paid Time Off:
    • US Exempt Employees: Flexible time off (unlimited, with manager approval) and 11 paid national holidays (not applicable to employees in Phoenix, AZ, Puerto Rico, or Rayzebio).
    • Phoenix, AZ, Puerto Rico, and Rayzebio Exempt, Non-Exempt, Hourly Employees: 160 hours annual paid vacation for new hires with manager approval, 11 national holidays, and 3 optional holidays.
  • Based on eligibility, additional time off may include unlimited paid sick time, up to 2 paid volunteer days per year, summer hours flexibility, leaves of absence for medical, personal, parental, caregiver, bereavement, and military needs, and an annual Global Shutdown between Christmas and New Year’s Day.

All global full- and part-time employees actively employed at and paid directly by BMS at the end of the calendar year are eligible to participate in the Global Shutdown.